Dings, C.; Meiser, P.; Holzer, F.; Flegel, M.; Selzer, D.; Nagy, E.; Mösges, R.; Klussmann, J.P.; Lehr, T.
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics 2022, 14, 2059.
https://doi.org/10.3390/pharmaceutics14102059
AMA Style
Dings C, Meiser P, Holzer F, Flegel M, Selzer D, Nagy E, Mösges R, Klussmann JP, Lehr T.
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics. 2022; 14(10):2059.
https://doi.org/10.3390/pharmaceutics14102059
Chicago/Turabian Style
Dings, Christiane, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, Ralph Mösges, Jens Peter Klussmann, and Thorsten Lehr.
2022. "Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients" Pharmaceutics 14, no. 10: 2059.
https://doi.org/10.3390/pharmaceutics14102059
APA Style
Dings, C., Meiser, P., Holzer, F., Flegel, M., Selzer, D., Nagy, E., Mösges, R., Klussmann, J. P., & Lehr, T.
(2022). Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients. Pharmaceutics, 14(10), 2059.
https://doi.org/10.3390/pharmaceutics14102059